Evidence map›Paper›PMID 37116064›Full record

ReviewRambam Maimonides medical journal2023

Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment.

Abid Awisat, Shiri Keret, Amal Silawy, Lisa Kaly, Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Aniela Shouval, Doron Rimar, Gleb Slobodin

Abstract readReview
In one paragraph

Review in Rambam Maimonides medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abid AwisatRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Shiri KeretRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Amal SilawyRheumatology Clinic, Maccabi Health Services, Haifa, Israel.
Lisa KalyRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Itzhak RosnerRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Michael RozenbaumRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Nina BoulmanRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Aniela ShouvalRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Doron RimarRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Gleb SlobodinRheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell arteritis (GCA) is the most prevalent subtype of vasculitis in adults. In recent years, there has been substantial improvement in the diagnosis and treatment of GCA, mainly attributed to the introduction of highly sensitive diagnostic tools, incorporation of modern imaging modalities for diagnosis and monitoring of large-vessel vasculitis, and introduction of highly effective novel biological therapies that have revolutionized the field of GCA. This article reviews state-of-the-art approaches for the diagnosis, monitoring, and treatment options of GCA.

Identifiers

PMID37116064
PMCPMC10147399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.